EDAP TMS reported EUR8.81M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AngioDynamics USD 36.57M 3.79M Sep/2025
Boston Scientific USD 1.78B 53M Mar/2026
EDAP TMS EUR 8.81M 1.57M Sep/2025
Henry Schein USD 809M 1000K Mar/2026
Medtronic 2.96B 9M Dec/2025
Plus Therapeutics USD 3.49M 559K Dec/2025
Veracyte USD 50.84M 7.53M Mar/2026